Asia Pacific Departmental Pacs Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2024 –2031 |
 시장 규모(기준 연도) |
USD 3.19 Billion |
 시장 규모(예측 연도) |
USD 5.19 Billion |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
>부서용 PACS 시장, 제품 유형(전통적인 PACS, 특수 PACS), 구성 요소(소프트웨어, 서비스, 하드웨어), 애플리케이션(MRI, 컴퓨터 단층촬영, 디지털 방사선 촬영, 초음파, 핵의학 영상, C-암 및 기타), 통합 수준(통합 PACS, 독립형 PACS), 최종 사용자(병원, 방사선과 체인/센터, 외래 수술 센터 및 기타), 유통 채널(직접 입찰, 제3자 관리자 및 기타) - 업계 동향 및 2031년까지의 예측.
APAC 부서별 PACS 시장 분석 및 통찰력
부서별 PACS 시장은 특정 병원 부서 또는 의료 전문 분야 내에서 의료 영상 데이터의 저장, 검색, 관리 및 배포에 전념하는 의료 정보 기술 부문의 세그먼트를 포함합니다. PACS는 현대 의료 영상 워크플로에 필수적이며, 방사선과 의사, 심장과 의사, 종양학자 및 기타 전문가가 X선, MRI, CT 스캔 및 초음파와 같은 진단 이미지를 디지털 방식으로 저장하고 액세스할 수 있도록 합니다. 이 시스템은 기존의 필름 기반 영상을 대체하여 영상 데이터의 효율성, 정확성 및 접근성을 개선하여 환자 치료를 향상시킵니다. 부서별 PACS는 개별 부서의 고유한 요구 사항과 워크플로를 충족하도록 맞춤화되어 있으며, 종종 특정 의료 관행에 대한 영상 프로세스를 간소화하는 특수 도구와 인터페이스를 제공합니다. 이러한 시스템은 다른 병원 정보 시스템(HIS) 및 전자 건강 기록(EHR)과의 원활한 통합을 용이하게 하여 환자 영상 데이터를 치료 연속체에서 쉽게 사용할 수 있도록 합니다. 부서 PACS 시장은 의료 영상 시술의 양 증가, 영상 기술의 발전, 향상된 진단 정확도에 대한 필요성, 의료의 디지털화 추진에 의해 주도됩니다. 또한, 규제 요건과 의료비 절감에 대한 강조는 부서 환경에서 PACS 도입을 더욱 촉진합니다. 의료 서비스 제공자가 효율적인 영상 데이터 관리와 향상된 환자 결과의 가치를 계속 인식함에 따라 부서 PACS 시장은 상당한 성장을 향해 나아가고 있습니다.
Data Bridge Market Research에 따르면 부서별 PACS 시장은 2023년 31억 9,000만 달러에서 2031년 51억 9,000만 달러로 성장할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 6.3%로 성장할 것으로 예상됩니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2024년부터 2031년까지 |
|
기준 연도 |
2023 |
|
역사적 연도 |
2022 (2016-2021년까지 사용자 정의 가능) |
|
양적 단위 |
매출 (USD) 10억 |
|
다루는 세그먼트 |
제품 유형(기존 PACS, 특수 PACS), 구성 요소(소프트웨어, 서비스, 하드웨어), 애플리케이션( 자기공명영상(MRI) , 컴퓨터단층촬영(CT), 디지털 방사선촬영, 초음파, 핵의학 영상, C-암, 기타), 통합 수준(통합 PACS, 독립형 PACS), 최종 사용자(병원, 방사선과 체인/센터, 외래 수술 센터 , 기타), 유통 채널(직접 입찰, 제3자 관리자, 기타) |
|
적용 국가 |
중국, 일본, 인도, 한국, 호주, 대만, 싱가포르, 태국, 인도네시아, 말레이시아, 필리핀, 뉴질랜드, 베트남, 기타 아시아 태평양 지역 |
|
시장 참여자 포함 |
FUJIFILM Corporation, GE Healthcare, Koninklijke Philips NV, Agfa-Gevaert Group, Hyland Software Inc., Lexmark International Inc., Mach 7 Technologies Limited, Novarad Enterprise Healthcare Solutions, Reyence, Siemens(Siemens Healthcare Private Limited), Sectra AB, Softneta, SinoVision, TeleRAD Reporting Services Private Limited, Voyager Imaging 등 |
시장 정의
부서별 PACS 시장은 특정 병원 부서 또는 의료 전문 분야 내에서 의료 영상 데이터의 저장, 검색, 관리 및 배포에 전념하는 의료 정보 기술 부문의 세그먼트를 포함합니다. PACS는 현대 의료 영상 워크플로에 필수적이며, 방사선과 의사, 심장과 의사, 종양학자 및 기타 전문가가 X선, MRI, CT 스캔 및 초음파와 같은 진단 이미지를 디지털 방식으로 저장하고 액세스할 수 있도록 합니다. 이 시스템은 기존의 필름 기반 영상을 대체하여 영상 데이터의 효율성, 정확성 및 접근성을 개선하여 환자 치료를 향상시킵니다. 부서별 PACS는 개별 부서의 고유한 요구 사항과 워크플로를 충족하도록 맞춤화되어 있으며, 종종 특정 의료 관행에 대한 영상 프로세스를 간소화하는 특수 도구와 인터페이스를 제공합니다. 이러한 시스템은 다른 병원 정보 시스템(HIS) 및 전자 건강 기록(EHR)과의 원활한 통합을 용이하게 하여 환자 영상 데이터를 치료 연속체에서 쉽게 사용할 수 있도록 합니다. 부서 PACS 시장은 의료 영상 시술의 양 증가, 영상 기술의 발전, 향상된 진단 정확도에 대한 필요성, 의료의 디지털화 추진에 의해 주도됩니다. 또한, 규제 요건과 의료비 절감에 대한 강조는 부서 환경에서 PACS 도입을 더욱 촉진합니다. 의료 서비스 제공자가 효율적인 영상 데이터 관리와 향상된 환자 결과의 가치를 계속 인식함에 따라 부서 PACS 시장은 상당한 성장을 향해 나아가고 있습니다.
부서별 PACS 시장 동향
이 섹션에서는 시장 동인, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전사
- 조기 질병 감지에 대한 수요 증가
The rising demand for early disease detection significantly drives the APAC Departmental PACS (Picture Archiving and Communication System) market, primarily because PACS technology enhances the efficiency and accuracy of diagnostic processes. Early disease detection often relies on advanced imaging techniques, which generate vast amounts of data needing efficient storage, retrieval, and analysis. PACS systems provide a digital solution to manage this data, allowing for quick and easy access to medical images and associated information. This capability is crucial for early disease detection, where timely and precise diagnosis can drastically improve patient outcomes. Also, the growing awareness and adoption of preventive healthcare measures in the APAC region have led to increased investments in healthcare infrastructure, including imaging technologies and PACS systems. Governments and healthcare organizations are prioritizing early detection programs to reduce the long-term burden of chronic diseases, further boosting the demand for robust PACS solutions. The integration of artificial intelligence (AI) and machine learning (ML) with PACS is also accelerating this trend, as these technologies enhance image analysis, improve diagnostic accuracy, and facilitate the early identification of diseases. Consequently, the escalating emphasis on early disease detection is propelling the expansion of the APAC Departmental PACS market as healthcare providers strive to adopt innovative solutions to meet the growing demand for efficient and effective diagnostic tools.
For instance,
- In November 2023, according to an article published in the journal Radiology Oncology Systems, PACS explored diagnostic imaging equipment’s pivotal role in identifying diseases at their earliest stages. Diagnostic imaging techniques such as X-rays, CT scans, PET scans, MRIs, and ultrasounds remain the frontline defenders against hidden health threats. They enable healthcare professionals to peer inside the body, unveiling anomalies, often before symptoms surface. In a recent study, it was revealed that early diagnosis through diagnostic imaging led to an approximately 20% increase in the effectiveness of cancer treatment options for lung cancer (American Association for Cancer Research). PACS plays a vital role in the prevention and treatment of disease
- In November 2022, according to an article published in GE HealthCare, when patients are disadvantaged from achieving their full health potential, health inequities are reflected in differences in length of life, quality of life, rates of disease, disability, and death, severity of disease, and access to treatment. The inability to access important components in the care path, such as medical imaging, can have a dramatic effect on health outcomes. Advanced medical imaging systems like PACS are needed to focus on the early diagnosis of non-communicable or chronic diseases, such as cardiovascular diseases, chronic respiratory diseases, and diabetes. Early Diagnosis is necessary to avoid further illness and wrong treatment and expenditure.
- In August 2020, according to the report published by EIT Health, new healthcare technologies like PACS constantly developed at a rapid pace and allowed for detection and diagnosis of diseases at an earlier stage. This trend, also known as early diagnostics, is expected to lead to significant change within healthcare systems as the way that diseases are found and treated are set to be reshaped. It has the potential to improve the quality of care, lower costs and provide treatment at an earlier time. Reducing downstream treatment costs for payers and society, lowering hospitalization rates and pressure on hospitals and clinicians, prescribing the right treatment for a patient, avoiding unnecessary intervention
The growing focus on early disease detection is a significant driver of the APAC Departmental PACS market because PACS technology streamlines the management of vast imaging data, which is crucial for timely and accurate diagnoses. As preventive healthcare gains traction in the region, investments in PACS systems increase, supported by the integration of AI and ML for enhanced diagnostic precision. This trend underscores the critical role of PACS in meeting the rising demand for effective diagnostic tools, thereby fostering market growth.
Restraint
- High Costs Associated with the Implementation of Medical Imaging Management
The high costs associated with the implementation of medical imaging management systems, such as PACS (Picture Archiving and Communication Systems), acts as a significant restraint for the APAC Departmental PACS market. These costs encompass not only the initial investment in sophisticated hardware and software but also the ongoing expenses related to system maintenance, upgrades, and training of medical staff. Smaller healthcare facilities and those in developing regions within the APAC market often face budget constraints, making it challenging to allocate sufficient funds for these advanced imaging management solutions. Furthermore, the financial burden of integrating PACS with existing hospital information systems and ensuring data security and compliance with healthcare regulations adds to the overall cost. These economic challenges can deter healthcare providers from adopting PACS technology despite its benefits in enhancing diagnostic accuracy and operational efficiency. As a result, the market growth of PACS in the APAC region may be hindered, particularly in less affluent areas where the high costs of implementation and maintenance present a significant barrier to adoption.
For instance,
- In April 2024, according to an article by Appinventiv, one of the world’s largest IT services providers, the average cost of developing PACS & DICOM medical imaging software varied from USD 30,000 to USD 300,000. This cost was affected by factors such as software complexity, delivery timelines, location of the hired software development firm, compliance with regulatory standards like HIPAA, and the level of expertise required from the development team. This acted as restraint and hindered the growth of the market
- In November 2019, PACS represented a significant investment as it was a separate software application that had to be purchased independently of the existing Vendor Neutral Archive (VNA) and DICOM viewers. During recent developments, PACS came with high costs, which became a significant restraint in the medical device market. Additionally, integrating a VNA into an existing PACS setup could involve substantial additional expenses, further adding to the financial burden and acted as a restraint in the growth of the market
The high costs of implementing medical imaging management systems, including PACS, act as a significant restraint for the APAC Departmental PACS market. These expenses, which cover initial investments, ongoing maintenance, system upgrades, and staff training, can be prohibitive for smaller or budget-constrained healthcare facilities. The financial burden of integrating PACS with existing systems and ensuring regulatory compliance further exacerbates this challenge. As a result, these high costs can limit the adoption of PACS technology, particularly in less affluent regions, and impede market growth.
Opportunity
- Adoption of AI Technology in Imaging
The adoption of AI technology in imaging presents significant opportunities for the APAC Departmental PACS (Picture Archiving and Communication Systems) market by enhancing diagnostic accuracy, efficiency, and workflow automation. AI-powered algorithms can analyze medical images with high precision, assisting radiologists in detecting anomalies, diagnosing conditions, and prioritizing urgent cases more effectively. This integration streamlines the imaging process, reducing the time required for image analysis and interpretation, which is crucial in high-volume settings. AI enhances the functionality of PACS systems by enabling advanced features such as automated image segmentation, predictive analytics, and decision support tools, which improve overall clinical outcomes. As healthcare providers in the APAC region increasingly seek to leverage AI to manage the growing volume of medical images and optimize diagnostic workflows, the demand for PACS systems that incorporate these advanced technologies is expected to rise. This shift not only positions PACS systems as integral components of modern healthcare infrastructure but also opens up new avenues for innovation and market growth in the APAC region.
For instance,
- In June 2024, according to news report published by MIT news, mentioning that Artificial intelligence and PACS often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. These models have also been shown to develop some surprising abilities. In 2022, MIT researchers reported that AI models will expect to make accurate predictions about a patient’s race from their chest X-rays. Their research team has now found that the models that are most accurate at making demographic predictions
- In June 2024, according to news report published by MIT news, reporting that as of May 2024, the FDA has approved 882 AI-enabled medical devices, with 671 of them designed to be used in radiology. Since 2022, when Ghassemi and her colleagues showed that these diagnostic models can accurately predict race, they and other researchers have shown that such models are also very good at predicting gender and age, even though the models are not trained on those tasks
- In March 2024, according to an article published by Elsevier, highlighting about the AI domains such as enhanced image analysis, operational efficiency, predictive and personalized healthcare, and clinical decision support in diagnostic imaging. Concluded that AI is revolutionizing diagnostic imaging by improving accuracy, efficiency, and personalized healthcare delivery
- In April 2024, according to an article published by Elsevier, aimed at mapping the available technology instruments to improve access to imaging at primary health care; to identify the facilitators and barriers, and the knowledge gaps for widespread adaptation of technology solutions. Suggests that teleradiology when combined with AI and mobile digital imaging units can address radiologist shortages; strengthen programs aimed at population screening and emergency care
The adoption of AI technology in imaging creates substantial opportunities for the APAC Departmental PACS market by enhancing diagnostic accuracy and workflow efficiency. AI enables advanced features like automated image analysis and predictive analytics, which streamline the imaging process and improve clinical outcomes. As healthcare providers in APAC increasingly integrate AI to handle growing imaging demands, the need for advanced PACS systems is expected to rise, driving market growth and innovation.
Challenge
- Data Security and Privacy Concerns due to Technical Complexity
Picture Archiving and Communication Systems (PACS) are sophisticated technologies that require advanced IT expertise for installation, configuration, and maintenance. The technical demands associated with these systems can lead to substantial operational costs and resource allocation challenges. Ensuring system reliability and minimizing downtime is essential, as disruptions such as system failures, data loss, or software glitches can delay access to critical medical images, which in turn affects diagnostic accuracy and treatment timeliness. The necessity for specialized IT support for troubleshooting and ongoing system updates further complicates and increases the cost of maintaining these systems.
For instance,
- In December 2020, according to an article published by NIST, securing PACS was challenging due to the varied medical imaging needs across different departments within healthcare organizations (HDOs) and the use of multiple PACS or archiving systems. Additionally, external imaging specialists were involved, and diverse clinical users accessed PACS from different locations, creating a complex environment that increased cybersecurity risks
- This complexity posed a challenge for the Asia Pacific Departmental PACS market by making it difficult to ensure robust cybersecurity measures across a fragmented and widely accessed PACS ecosystem
- According to an article published by Open MedScience, PACS systems depends on complex technology, which can lead to issues such as system failures, data loss, and software glitches, causing downtime and delays in patient care. Additionally, PACS requires specialized and often costly training for radiology staff, with ongoing updates needed to keep pace with technological advancements. This challenge impacts the Asia Pacific Departmental PACS Market by increasing operational costs and potentially disrupting patient care due to technical issues and the need for continuous staff training
The technical complexity heightens concerns about data security and privacy, as managing and protecting sensitive medical information across diverse and intricate systems can be particularly challenging, impacting the overall efficiency and security of healthcare facilities.
Recent Developments
- In January 2024, FUJIFILM Diosynth Biotechnologies and SHL Medical entered strategic partnership agreement to help meet growing market demand for autoinjector medicines. The partnership, part of SHL’s Alliance Management Program, aimed to streamline processes and enhance efficiency for pharmaceutical and biotech companies offering self-injection device finished goods services primarily with SHL’s flagship platform Molly
- In August 2022, the Agfa-Gevaert Group signed a share purchase agreement with AURELIUS Group for the sale of its Offset Solutions division within the framework of its ongoing transformation process. The sales enabled the Group to increase the focus on its growth businesses
Departmental PACS Market Scope
The departmental PACS market is segmented into six notable segments based on Product Type, Component, Application, Integration Level, End User, Distribution Channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
By Product Type (Traditional PACS, Specialty PACS), Component (Software, Services, Hardware), Application (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Digital Radiography, Ultrasound, Nuclear Imaging, C-Arms, Others), Integration Level (Integrated PACS, Standalone PACS), End User (Hospital, Radiology Chains/Centers, Ambulatory Surgery Centers, Others), Distribution Channel (Direct Tenders, Third Party Administrators, Others)
Product Type
- Traditional PACS
- Specialty PACS
On the basis of product type, the market is segmented into traditional PACS, and speciality PACS.
Component
- Software
- Services
- Hardware
On the basis of component, the market is segmented into software, services, and hardware.
Application
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Digital Radiography
- Ultrasound
- Nuclear Imaging
- C-Arms
- Others
On the basis of application, the market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), digital radiography, ultrasound, nuclear imaging, c-arms, and others.
Integration Level
- Integrated PACS
- Standalone PACS
On the basis of integration level, the market is segmented into integrated PACS, and standalone PACS.
End User
- Hospitals
- Radiology Chains/Centers,
- Ambulatory Surgical Centers
- Others
On the basis of end user, the market is segmented into hospitals, radiology chains/centers, ambulatory surgical centers, and others.
Distribution Channel
- Direct Tenders
- Third Party Administrators
- Others
On the basis of distribution channel, the market is segmented into direct tenders, third party administrators, and others.
Departmental PACS Market Regional Analysis/Insights
The departmental PACS market is segmented into nine notable segments based on Product Type, Component, Application, Integration Level, End User, and Distribution Channel.
The countries covered in this market report are China, Japan, India, South Korea, Australia, Taiwan, Singapore, Thailand, Indonesia, Malaysia, Philippines, New Zealand, Vietnam, rest of Asia-Pacific.
Japan is growing in the APAC departmental PACS market and is expected to dominate the market with an increasing prevalence of chronic disorders in the country.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and APAC Departmental PACS Market Share Analysis
The departmental PACS market competitive landscape provides details of competitors. Details included are compmarketany overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players are FUJIFILM Corporation, GE Healthcare, Koninklijke Philips N.V., Agfa-Gevaert Group, Hyland Software Inc., Lexmark International Inc., Mach 7 Technologies Limited, Novarad Enterprise Healthcare Solutions, Reyence, Siemens (Siemens Healthcare Private Limited), Sectra AB, Softneta, SinoVision, TeleRAD Reporting Services Private Limited, and Voyager Imaging among others.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING DEMAND FOR EARLY DISEASE DETECTION
6.1.2 INCREASING IMAGING EQUIPMENT USAGE
6.1.3 THE PREVALENCE OF CHRONIC DISEASE AND PAIN-RELATED CONDITIONS
6.1.4 RISE IN BONE INJURIES AND ORTHOPEDIC CONDITIONS AND ITS IMAGING
6.2 RESTRAINTS
6.2.1 HIGH COSTS ASSOCIATED WITH THE IMPLEMENTATION OF MEDICAL IMAGING MANAGEMENT
6.2.2 STRINGENT REGULATORY REQUIREMENTS INVOLVED IN THE MANAGEMENT PROCESS
6.3 OPPORTUNITIES
6.3.1 ADOPTION OF AI TECHNOLOGY IN IMAGING
6.3.2 IMPROVEMENT IN GOVERNMENTAL STANDARDS AND POLICIES
6.3.3 ADVANCEMENTS IN RESEARCH AND DEVELOPMENT
6.4 CHALLENGES
6.4.1 DATA SECURITY AND PRIVACY CONCERNS DUE TO TECHNICAL COMPLEXITY
6.4.2 INCREASING IN THE INTEROPERABILITY ISSUES
7 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 TRADITIONAL PACS
7.2.1 IMAGE PROCESSING
7.2.2 IMAGE MANAGEMENT
7.3 SPECIALITY PACS
7.3.1 CARDIOLOGY PACS
7.3.2 ONCOLOGY PACS
7.3.3 PATHOLOGY PACS
7.3.4 ORTHOPEDIC PACS
7.3.5 DERMATOLOGY PACS
7.3.6 OPTHALMOLOGY PACS
7.3.7 DENTAL PACS
7.3.8 VETERINARY PACS
7.3.9 OTHERS
8 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT
8.1 OVERVIEW
8.2 SOFTWARE
8.2.1 WEB/ CLOUD BASED
8.2.2 ON PREMISES
8.2.3 HYBRID
8.3 SERVICES
8.4 HARDWARE
9 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 MAGNETIC RESONANCE IMAGING (MRI)
9.3 COMPUTED TOMOGRAPHY (CT)
9.4 DIGITAL RADIOGRAPHY
9.5 ULTRASOUND
9.6 NUCLEAR IMAGING
9.7 C-ARMS
9.8 OTHERS
10 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL
10.1 OVERVIEW
10.2 INTEGRATED PACS
10.3 STANDALONE PACS
11 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 LARGE HOSPITALS
11.2.1.2 MEDIUM-SIZED HOSPITALS
11.2.1.3 SMALL HOSPITALS
11.3 RADIOLOGY CHAINS/ CENTERS
11.4 AMBULATORY SURGERY CENTERS
11.5 OTHERS
12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDERS
12.3 THIRD PARTY ADMINISTRATORS
12.4 OTHERS
13 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY
13.1 ASIA-PACIFIC
13.1.1 JAPAN
13.1.2 CHINA
13.1.3 AUSTRALIA
13.1.4 INDIA
13.1.5 SOUTH KOREA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 VIETNAM
13.1.11 PHILIPPINES
13.1.12 REST OF ASIA-PACIFIC
14 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 FUJIFILM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENT
16.2 GE HEALTHCARE
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 KONINKLIJKE PHILIPS N.V.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 AGFA-GEVAERT GROUP.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 HYLAND SOFTWARE, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 PRODUCT PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 LEXMARK INTERNATIONAL, INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 MACH 7 TECHNOLOGIES LIMITED
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 NOVARAD ENTERPRISE HEALTHCARE SOLUTIONS
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 RAYENCE
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 SIEMENS (SIEMENS HEALTHCARE PRIVATE LIMITED)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 SECTRA AB
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 SOFTNETA
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 SINOVISION
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 TELERAD REPORTING SERVICES PRIVATE LIMITED
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 VOYAGER IMAGING
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC (APAC) IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC (APAC) SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC (APAC) CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC (APAC) ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC (APAC) ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC (APAC) DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC (APAC) OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC (APAC) VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 20 JAPAN DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 21 JAPAN TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 22 JAPAN IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 JAPAN SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 24 JAPAN CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 25 JAPAN ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 26 JAPAN ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 27 JAPAN DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 28 JAPAN OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 29 JAPAN DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 30 JAPAN VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 31 JAPAN DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 32 JAPAN SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 33 JAPAN DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 34 JAPAN DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 35 JAPAN DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 36 JAPAN HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 JAPAN DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 38 CHINA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 CHINA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 40 CHINA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 41 CHINA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 CHINA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 43 CHINA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 44 CHINA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 45 CHINA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 46 CHINA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 47 CHINA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 48 CHINA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 49 CHINA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 50 CHINA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 51 CHINA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 52 CHINA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 53 CHINA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 54 CHINA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 CHINA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 56 AUSTRALIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 AUSTRALIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 58 AUSTRALIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 AUSTRALIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 AUSTRALIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 61 AUSTRALIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 62 AUSTRALIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 63 AUSTRALIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 64 AUSTRALIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 65 AUSTRALIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 66 AUSTRALIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 67 AUSTRALIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 68 AUSTRALIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 AUSTRALIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 70 AUSTRALIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 71 AUSTRALIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 72 AUSTRALIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 AUSTRALIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 74 INDIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 INDIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 76 INDIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 INDIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 INDIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 79 INDIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 80 INDIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 81 INDIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 82 INDIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 83 INDIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 84 INDIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 85 INDIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 86 INDIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 INDIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 88 INDIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 89 INDIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 90 INDIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 91 INDIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 92 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 SOUTH KOREA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 94 SOUTH KOREA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 SOUTH KOREA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 SOUTH KOREA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 97 SOUTH KOREA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 98 SOUTH KOREA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 99 SOUTH KOREA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 100 SOUTH KOREA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 101 SOUTH KOREA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 102 SOUTH KOREA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 103 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 104 SOUTH KOREA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 106 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 107 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 108 SOUTH KOREA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 110 SINGAPORE DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 SINGAPORE TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 112 SINGAPORE IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 SINGAPORE SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 SINGAPORE CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 115 SINGAPORE ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 116 SINGAPORE ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 117 SINGAPORE DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 118 SINGAPORE OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 119 SINGAPORE DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 120 SINGAPORE VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 121 SINGAPORE DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 122 SINGAPORE SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 SINGAPORE DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 124 SINGAPORE DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 125 SINGAPORE DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 126 SINGAPORE HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 SINGAPORE DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 128 MALAYSIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 MALAYSIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 130 MALAYSIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 MALAYSIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 MALAYSIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 133 MALAYSIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 134 MALAYSIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 135 MALAYSIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 136 MALAYSIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 137 MALAYSIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 138 MALAYSIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 139 MALAYSIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 140 MALAYSIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 MALAYSIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 142 MALAYSIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 143 MALAYSIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 144 MALAYSIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 MALAYSIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 146 THAILAND DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 THAILAND TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 148 THAILAND IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 THAILAND SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 THAILAND CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 151 THAILAND ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 152 THAILAND ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 153 THAILAND DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 154 THAILAND OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 155 THAILAND DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 156 THAILAND VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 157 THAILAND DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 158 THAILAND SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 THAILAND DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 160 THAILAND DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 161 THAILAND DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 162 THAILAND HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 163 THAILAND DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 164 INDONESIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 INDONESIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 166 INDONESIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 INDONESIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 INDONESIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 169 INDONESIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 170 INDONESIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 171 INDONESIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 172 INDONESIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 173 INDONESIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 174 INDONESIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 175 INDONESIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 176 INDONESIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 INDONESIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 178 INDONESIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 179 INDONESIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 180 INDONESIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 INDONESIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 182 VIETNAM DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 VIETNAM TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 184 VIETNAM IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 VIETNAM SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 VIETNAM CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 187 VIETNAM ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 188 VIETNAM ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 189 VIETNAM DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 190 VIETNAM OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 191 VIETNAM DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 192 VIETNAM VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 193 VIETNAM DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 194 VIETNAM SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 VIETNAM DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 196 VIETNAM DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 197 VIETNAM DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 198 VIETNAM HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 VIETNAM DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 200 PHILIPPINES DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 PHILIPPINES TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 202 PHILIPPINES IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 PHILIPPINES SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 204 PHILIPPINES CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 205 PHILIPPINES ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 206 PHILIPPINES ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 207 PHILIPPINES DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 208 PHILIPPINES OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 209 PHILIPPINES DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 210 PHILIPPINES VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 211 PHILIPPINES DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 212 PHILIPPINES SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 213 PHILIPPINES DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 214 PHILIPPINES DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 215 PHILIPPINES DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 216 PHILIPPINES HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 PHILIPPINES DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 218 REST OF ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
그림 목록
FIGURE 1 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: ASIA-PACIFIC VS REGIONS MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 11 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISION
FIGURE 14 RISING DEMAND FOR EARLY DISEASE DETECTION IS DRIVING THE GROWTH OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET FROM 2024 TO 2031
FIGURE 15 THE MIXERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2023
FIGURE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 20 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2023
FIGURE 22 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2024-2031 (USD THOUSAND)
FIGURE 23 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 24 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2023
FIGURE 26 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2023
FIGURE 30 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2024-2031 (USD THOUSAND)
FIGURE 31 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, CAGR (2024-2031)
FIGURE 32 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER 2023
FIGURE 34 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 35 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: END USER, CAGR (2024-2031)
FIGURE 36 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 38 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 39 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 40 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SNAPSHOT (2023)
FIGURE 42 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY SHARE 2023 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
